Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
1000-1017
Author(s):
Gang Niu and Xiaoyuan Chen
Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
285-296
Author(s):
N. Ticozzi, A. Ratti and V. Silani
Human Mesenchymal Stem Cells (hMSCs) as Targets of DNA Damaging Agents in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
411-421
Author(s):
S. Cruet-Hennequart, A.M. Prendergast, F.P. Barry and M.P. Carty
CD133 Expressing Pericytes and Relationship to SDF-1 and CXCR4 in Spinal Cord Injury
Journal:
Current Neurovascular Research
Volume:
7
Page:
144-154
Author(s):
Ursula Graumann, Marie-Francoise Ritz, Bertha Gutierrez Rivero and Oliver Hausmann
Efficient Growth Inhibition of Human Osteosarcoma Cells Using a Peptide Derived from the MDM-2-Binding Site of p53
Journal:
Protein & Peptide Letters
Volume:
17
Page:
610-615
Author(s):
R. Ito, H. Kanno, A. Takahashi, R. Matsumoto, N. Kobayashi, T. Yoshida and T. Saito
Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Journal:
Current Drug Targets
Volume:
11
Page:
291-302
Author(s):
Vladimir Krystof and Stjepan Uldrijan
Future Prospect of RNA Interference for Cancer Therapies
Journal:
Current Drug Targets
Volume:
11
Page:
345-360
Author(s):
Eishi Ashihara, Eri Kawata and Taira Maekawa
Valproic Acid in the Complex Therapy of Malignant Tumors
Journal:
Current Drug Targets
Volume:
11
Page:
361-379
Author(s):
J. Hrebackova, J. Hrabeta and T. Eckschlager
Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
196-212
Author(s):
T. Shalaby, E. Hiyama and M.A. Grotzer
Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
200-209
Author(s):
F. Navid, V. M. Santana and R. C. Barfield